English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Trovagene Inc.
Press release submission
| Feb 14, 2019
TROVAGENE, INC.: Presents Update on Phase 2 Study of Onvansertib in Combination with Zytiga in Patients with mCRPC at ASCO-GU Conference
Jamie Barrand
| Sep 23, 2015
Data looks favorable for Trovagene's HPV HR test
Trending
Patient Daily
| Oct 23, 2025
Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily
| Oct 23, 2025
Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+
Pharmaceuticals
Patient Daily
| Oct 23, 2025
Empower seeks dismissal of Eli Lilly suit in Texas federal court
+
Pharmaceuticals
Patient Daily
| Oct 29, 2025
Paragon Health Institute senior fellow: 340B program 'needs real reform'
